10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 341 filers reported holding 10X GENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,723,631 | -24.5% | 41,785 | +2.3% | 0.10% | -21.4% |
| Q2 2023 | $2,281,901 | -0.4% | 40,865 | -0.5% | 0.13% | -6.7% |
| Q1 2023 | $2,291,574 | +74.9% | 41,075 | +14.3% | 0.14% | +66.7% |
| Q4 2022 | $1,309,981 | +34.1% | 35,949 | +4.8% | 0.08% | +20.9% |
| Q3 2022 | $977,000 | -46.0% | 34,308 | -14.2% | 0.07% | -43.7% |
| Q2 2022 | $1,808,000 | -41.0% | 39,972 | -0.8% | 0.12% | -29.6% |
| Q1 2022 | $3,066,000 | -40.6% | 40,303 | +16.3% | 0.17% | -35.0% |
| Q4 2021 | $5,161,000 | +8.2% | 34,651 | +5.8% | 0.26% | -0.8% |
| Q3 2021 | $4,768,000 | +7.6% | 32,749 | +44.7% | 0.26% | +6.5% |
| Q2 2021 | $4,433,000 | +25.4% | 22,638 | +15.9% | 0.25% | +16.0% |
| Q1 2021 | $3,536,000 | – | 19,534 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |